Dr. Peter Rice of the CU Skaggs School of Pharmacy and Pharmaceutical Sciences talks about sunscreen safety, what chemicals it is made of and how best to use it.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045
Dr. Peter Rice of the CU Skaggs School of Pharmacy and Pharmaceutical Sciences talks about sunscreen safety, what chemicals it is made of and how best to use it.
Longmont’s Robauto is working with a Denver software startup to bring artificial intelligence-powered therapy to kids dealing with behavioral issues. The app, which was designed in collaboration with Children’s Hospital of Colorado and the University of Colorado Anschutz Medical Campus, is being tweaked, said Manatee CEO and co-founder Dama Dipayana. The app is part of an effort to make mental health care accessible for kids, she said.
An approved epileptic drug to treat seizures has been modified by a University of Colorado Anschutz Medical Campus professor and is currently being used in a clinical trial in Australia for medically refractory epilepsy. Tom Anchordoquy, PhD, professor at the CU Skaggs School of Pharmacy and Pharmaceutical Sciences, and Dan Abrams, MD, CEO of Cerebral Therapeutics, have developed a proprietary reformulated specialty pharmaceutical, which bypasses the blood-brain barrier using a chronic implantable infusion system, to improve the lives of patients with severe medically refractory epilepsy.
“We as women have a lot of power, but we’re only going to get so far unless we have men who can take a stand as well,” said Elizabeth McCullagh, a postdoctoral fellow at the CU Anschutz Medical Campus. McCullagh also serves on the leadership board of the group 500 Women Scientists, a group that works to expand diversity in science. The organization represents more than 11,000 women around the world qualified to be on the very panels to which Collins referred.
As more states legalize medical and recreational cannabis, the number of older Americans using the drug is expected to rise, said Dr. Hillary Lum, assistant professor at the University of Colorado School of Medicine and co-author of a study published last month in the journal Drugs and Aging that examined pot use among Americans over age 60. The University of Colorado study comes as a number of researchers look into the impact marijuana may have on certain health issues, including obsessive compulsive disorder, cancer and ADHD. However, Lum said there’s still research that needs to be done on cannabis as a medical treatment.
Colorado has sixteen active or future clinical marijuana studies, making it fourth highest in number of studies behind Connecticut (35), California (23) and New York (23). The majority of the studies in Colorado involved institutions such as the University of Colorado and Children's Hospital Colorado and are researching marijuana's effects on breast milk, cancer patients, chronic pain, Parkinson's and other ailments.
Dr. Hillary Lum of the University of Colorado School of Medicine says seniors facing barriers when trying to access cannabis.
Dr. Hillary Lum of the CU School of Medicine says more older Americans are using cannabis for health reasons yet their doctors are often ill-equipped to offer them guidance.
13001 East 17th Place
Aurora, CO 80045
303-724-9290
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.